Doxycycline is not a primary treatment for systemic lupus erythematosus (SLE). However, it can be used as an adjunct therapy, particularly for managing skin lesions and possibly reducing inflammation. Its efficacy in treating infections in SLE patients is similar to its use in the general population, making it a suitable option when typical antibiotics are indicated.